264 related articles for article (PubMed ID: 19924760)
1. Investigation of trypanothione reductase as a drug target in Trypanosoma brucei.
Spinks D; Shanks EJ; Cleghorn LA; McElroy S; Jones D; James D; Fairlamb AH; Frearson JA; Wyatt PG; Gilbert IH
ChemMedChem; 2009 Dec; 4(12):2060-9. PubMed ID: 19924760
[TBL] [Abstract][Full Text] [Related]
2. Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei.
Lu J; Vodnala SK; Gustavsson AL; Gustafsson TN; Sjöberg B; Johansson HA; Kumar S; Tjernberg A; Engman L; Rottenberg ME; Holmgren A
J Biol Chem; 2013 Sep; 288(38):27456-27468. PubMed ID: 23900839
[TBL] [Abstract][Full Text] [Related]
3. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
[TBL] [Abstract][Full Text] [Related]
4. Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis.
Richardson JL; Nett IR; Jones DC; Abdille MH; Gilbert IH; Fairlamb AH
ChemMedChem; 2009 Aug; 4(8):1333-40. PubMed ID: 19557801
[TBL] [Abstract][Full Text] [Related]
5. Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography.
Patterson S; Alphey MS; Jones DC; Shanks EJ; Street IP; Frearson JA; Wyatt PG; Gilbert IH; Fairlamb AH
J Med Chem; 2011 Oct; 54(19):6514-30. PubMed ID: 21851087
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
Jagu E; Pomel S; Diez-Martinez A; Ramiandrasoa F; Krauth-Siegel RL; Pethe S; Blonski C; Labruère R; Loiseau PM
Bioorg Med Chem; 2017 Jan; 25(1):84-90. PubMed ID: 27793448
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductase.
Patterson S; Jones DC; Shanks EJ; Frearson JA; Gilbert IH; Wyatt PG; Fairlamb AH
ChemMedChem; 2009 Aug; 4(8):1341-53. PubMed ID: 19557802
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.
Spinks D; Torrie LS; Thompson S; Harrison JR; Frearson JA; Read KD; Fairlamb AH; Wyatt PG; Gilbert IH
ChemMedChem; 2012 Jan; 7(1):95-106. PubMed ID: 22162199
[TBL] [Abstract][Full Text] [Related]
9. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
[TBL] [Abstract][Full Text] [Related]
10. Bistacrines as potential antitrypanosomal agents.
Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
[TBL] [Abstract][Full Text] [Related]
11. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal-antiplasmodial activity.
Sola I; Castellà S; Viayna E; Galdeano C; Taylor MC; Gbedema SY; Pérez B; Clos MV; Jones DC; Fairlamb AH; Wright CW; Kelly JM; Muñoz-Torrero D
Bioorg Med Chem; 2015 Aug; 23(16):5156-67. PubMed ID: 25678015
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
[TBL] [Abstract][Full Text] [Related]
14. A novel microwave synthesis of quinoline-3-carboxylic acid derivatives for treatment against human African trypanosomiasis.
Samant BS; Nyangari N
Mol Divers; 2012 Nov; 16(4):685-95. PubMed ID: 23054534
[TBL] [Abstract][Full Text] [Related]
15. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis.
Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR
Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377
[TBL] [Abstract][Full Text] [Related]
16. Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.
Zimmermann S; Oufir M; Leroux A; Krauth-Siegel RL; Becker K; Kaiser M; Brun R; Hamburger M; Adams M
Bioorg Med Chem; 2013 Nov; 21(22):7202-9. PubMed ID: 24080104
[TBL] [Abstract][Full Text] [Related]
17. From on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules.
Woodland A; Grimaldi R; Luksch T; Cleghorn LA; Ojo KK; Van Voorhis WC; Brenk R; Frearson JA; Gilbert IH; Wyatt PG
ChemMedChem; 2013 Jul; 8(7):1127-37. PubMed ID: 23776181
[TBL] [Abstract][Full Text] [Related]
18. Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme.
Turcano L; Battista T; De Haro ET; Missineo A; Alli C; Paonessa G; Colotti G; Harper S; Fiorillo A; Ilari A; Bresciani A
PLoS Negl Trop Dis; 2020 May; 14(5):e0008339. PubMed ID: 32437349
[TBL] [Abstract][Full Text] [Related]
19. Optimization of 2-(1H-imidazo-2-yl)piperazines series of Trypanosoma brucei growth inhibitors as potential treatment for the second stage of HAT.
Ciammaichella A; Ferrigno F; Basta A; D'Amico M; Biancofiore I; Nardi V; Ponzi S; Graziani R; Gennari N; Vittoria Orsale M; Fini I; Paonessa G; Summa V; Harper S; Ontoria JM
Bioorg Med Chem Lett; 2020 Jun; 30(12):127207. PubMed ID: 32354566
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of analogs of the phenylpyridazinone NPD-001 as potent trypanosomal TbrPDEB1 phosphodiesterase inhibitors and in vitro trypanocidals.
Veerman J; van den Bergh T; Orrling KM; Jansen C; Cos P; Maes L; Chatelain E; Ioset JR; Edink EE; Tenor H; Seebeck T; de Esch I; Leurs R; Sterk GJ
Bioorg Med Chem; 2016 Apr; 24(7):1573-81. PubMed ID: 26935942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
